- Trials with a EudraCT protocol (15)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
15 result(s) found for: Altered Mental State.
Displaying page 1 of 1.
EudraCT Number: 2019-002848-24 | Sponsor Protocol Number: IFT2019 | Start Date*: 2020-03-06 |
Sponsor Name:GIGA-Consciousness Thematic Unit, Anesthesia and Intensive Care Laboratory, Liege University | ||
Full Title: Brain functional signature of connected consciousness under general anesthesia using the isolated forearm technique | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002997-35 | Sponsor Protocol Number: OVG2014/05 | Start Date*: 2015-02-06 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A phase III multi-centre randomised, double blind, placebo controlled trial to assess the role of intravenous immunoglobulin in the management of children with encephalitis (The IgNiTE study) | |||||||||||||
Medical condition: Encephalitis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000829-55 | Sponsor Protocol Number: PSILO4ALCO | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | ||||||||||||||||||
Full Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial. | ||||||||||||||||||
Medical condition: Alcohol Use Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006773-38 | Sponsor Protocol Number: TSPOC5FOR2022 | Start Date*: 2022-11-29 |
Sponsor Name:Medizinische Einrichtungen des Berzirks Oberpfalz | ||
Full Title: TSPO ligands in the treatment of depression: proof-of-concept of efficacy and underlying mechanisms of action | ||
Medical condition: Unipolar/bipolar depressive disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004054-28 | Sponsor Protocol Number: Panorexia | Start Date*: 2020-06-23 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study | ||||||||||||||||||
Medical condition: Anorexia Nervosa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002824-17 | Sponsor Protocol Number: ACCOST-HH | Start Date*: 2019-02-28 | |||||||||||
Sponsor Name:University Medical Centre Hamburg-Eppendorf | |||||||||||||
Full Title: Placebo-controlled, double-blind, randomized trial to assess the efficacy and safety of Adrecizumab in subjects with cardiogenic shock | |||||||||||||
Medical condition: Cardiogenic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000219-18 | Sponsor Protocol Number: PsiloRCT001 | Start Date*: 2018-04-09 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms | ||||||||||||||||||
Medical condition: Major Depressive Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-001666-35 | Sponsor Protocol Number: Kar-013 | Start Date*: 2023-01-05 | |||||||||||
Sponsor Name:Karuna Therapeutics, Inc. | |||||||||||||
Full Title: An Open Label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects with Inadequately Controlled Symptoms of Schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002940-86 | Sponsor Protocol Number: SELLIFA-02 | Start Date*: 2007-08-24 | |||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc – Université catholique de Louvain | |||||||||||||
Full Title: Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and... | |||||||||||||
Medical condition: Liver failure, Liver cirrhosis, critical illness, total nutritional support | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008441-38 | Sponsor Protocol Number: ISRCTN76912190 | Start Date*: 2011-02-17 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind, placebo controlled trial | |||||||||||||
Medical condition: Postpartum haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004970-16 | Sponsor Protocol Number: CS15-033 | Start Date*: 2017-05-30 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Imaging the functional and molecular impact of poly-unsaturated fatty acids on dopamine-dependent cognitive functions: a combined [11C]-(+)-PHNO PET/MRI study at different stages of cognitive impai... | |||||||||||||
Medical condition: This study will assess the effects of poly-unsaturated fatty acids on working memory (measured using an n-back test) in healthy volunteers, in subjects who are at high risk for developing a psychot... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001665-12 | Sponsor Protocol Number: KAR-012 | Start Date*: 2023-01-05 | |||||||||||
Sponsor Name:Karuna Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Adjunctive KarXT in Subjects with Inadequately Controlled Symptoms of Schizophrenia. | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000222-19 | Sponsor Protocol Number: H2020-PHC-18-2015-667224 | Start Date*: 2017-08-02 | ||||||||||||||||
Sponsor Name:University Hospital Tuebingen | ||||||||||||||||||
Full Title: Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiori... | ||||||||||||||||||
Medical condition: Perinatal Asphyxia, hypoxic-ischemic brain injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Ongoing) NO (Ongoing) ES (Ongoing) FI (Ongoing) EE (Ongoing) AT (Ongoing) BE (Ongoing) PT (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005397-34 | Sponsor Protocol Number: Issue1 | Start Date*: 2012-02-24 | |||||||||||||||||||||
Sponsor Name:University Hospital Bristol NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Xenon and cooling therapy in babies at high risk of brain injury following poor condition at birth: Randomised pilot study. (CoolXenon2 study) | |||||||||||||||||||||||
Medical condition: Neonatal hypoxia-ischaemia (HI). There is no exact MedDRA term for this. The closest MedDRA terms matching this are neonatal asphyxia and neonatal hypoxia. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003895-35 | Sponsor Protocol Number: D4280C00005 | Start Date*: 2012-04-11 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole V... | |||||||||||||
Medical condition: Complicated Intra-Abdominal Infection (cIAI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) GR (Completed) ES (Completed) BG (Completed) IT (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.